Lingotto Investment Management LLP lifted its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 141.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,875,077 shares of the company’s stock after buying an additional 1,100,000 shares during the period. Recursion […]
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down to $15 52 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) COO Tina Marriott Larson sold 3,000 shares of the firm’s stock in a transaction on Thursday, September 28th. The shares were sold at an average price of $7.72, for a total value of $23,160.00. Following the completion of the sale, the chief operating officer now owns 418,782 […]
Platinum Investment Management Ltd. grew its position in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 2,770,451 shares of the company’s stock after buying an additional 60,112 shares during the period. Platinum Investment Management Ltd.’s […]
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) insider Shafique Virani sold 18,000 shares of the stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $9.25, for a total transaction of $166,500.00. Following the completion of the sale, the insider now directly owns 140,351 shares […]